Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Triple GIP/GLP-1/glucagon receptor co-agonists The success of dual receptor agonists for the treatment of type 2 diabetes and obesity in clinical trials, including the approval of one such drug by the FDA and EMA (currently only for type 2 diabetes), has prompted the search for new combinatorial approaches
The synchrotron radiation experiments were performed at the BL45XU of Spring-8, Japan
McGill et al
Circ Res
US$ 21.20
US$ 27.05
US$ 27.65
US$ 26.54
US$ 22.24
US$ 23.50
US$ 20.50
US$ 26.88
